ALLISON GABBERT: Open Payments
NPI 1932869724 · ALEXANDRIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$879 in 43 payments from 11 companies in 2025. Trend: 2023 $775 · 2024 $640 · 2025 $879
Food & beverage: $879
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $172 |
| PFIZER INC. | 10 | $158 |
| Lilly USA, LLC | 5 | $110 |
| ViiV Healthcare Company | 5 | $107 |
| AstraZeneca Pharmaceuticals LP | 3 | $73 |
| Exact Sciences Corporation | 3 | $66 |
| Astellas Pharma US Inc | 2 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $50 |
| ABBVIE INC. | 2 | $37 |
| Inspire Medical Systems, Inc. | 1 | $28 |
Products named: NURTEC ODT, APRETUDE, MOUNJARO, Ozempic, Veozah, ZEPBOUND, PREVNAR 20, AIRSUPRA.
Industry payments across VA — which companies pay providers there.
